Naturido alleviates amyloid β1–42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer’s disease
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0320636 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Piyamas Sillapakong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biococoon Laboratories, Inc., Morioka, Iwate, Japan. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Alzheimer Disease, Amyloid beta-Peptides, Peptide Fragments. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DKS Co., Ltd..
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily associated with aging. While the amyloid hypothesis is not the only explanation for AD pathogenesis, it is widely recognized that the accumulation of amyloid β (Aβ) protein triggers pathological changes in the brains of patients. In a previous study, we showed that Naturido, a cyclic peptide derived from the medicinal fungus ( Isaria japonica ) grown on domestic silkworms ( Bombyx mori ), could reverse several age-related deficits in senescence-accelerated mice. In this study, we explored the potential of Naturido to reduce Aβ-related toxicity in transgenic Caenorhabditis elegans models of AD, where human Aβ 1-42 protein is overexpressed in neurons. Our results demonstrated that Naturido administration alleviated various phenotypes, including Aβ-induced impairment in associative learning, serotonin hypersensitivity, and locomotion in the transgenic C. elegans . These findings suggest the potential of Naturido as a candidate molecule for the prevention and/or treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biococoon Laboratories, Inc., Morioka, Iwate, Japan.
- Department of Chemistry and Biological Sciences, Faculty of Science and Engineering, Iwate University, Morioka, Iwate, Japan.
ORCID-Profile: Tokumitsu Wakabayashi
Förderung
- DKS Co., Ltd.
Zitieren
APA
Sillapakong, P., Wakabayashi, T., & Suzuki, K. (2025). Naturido alleviates amyloid β1–42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer’s disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0320636
Vancouver
Sillapakong P, Wakabayashi T, Suzuki K. Naturido alleviates amyloid β1–42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer’s disease. PLOS ONE. 2025. doi:10.1371/journal.pone.0320636
BibTeX
@article{Sillapakong2025,
author = {Sillapakong, Piyamas and Wakabayashi, Tokumitsu and Suzuki, Koichi},
title = {Naturido alleviates amyloid β1–42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer’s disease},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0320636}
}
EUVIMED